<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00132171</url>
  </required_header>
  <id_info>
    <org_study_id>66/2000/J</org_study_id>
    <nct_id>NCT00132171</nct_id>
  </id_info>
  <brief_title>Helicobacter Pylori Eradication With a New Sequential Treatment</brief_title>
  <official_title>High Eradication Rates of Helicobacter Pylori With a New Sequential Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Orsola Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Orsola Hospital</source>
  <brief_summary>
    <textblock>
      Eradication rates of Helicobacter pylori (H. pylori) with standard triple therapy are
      disappointing, and studies from several countries confirm this poor performance. The study
      aimed to assess the eradication rate of a new sequential treatment regimen compared with
      conventional triple therapy for the eradication of H. pylori infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One thousand and forty-nine dyspeptic patients were studied prospectively. H. pylori-infected
      patients were randomized to receive 10-day sequential therapy [rabeprazole (20 mg twice
      daily) plus amoxicillin (1 g twice daily) for the first 5 days, followed by rabeprazole (20
      mg), clarithromycin (500 mg) and tinidazole (500 mg, all twice daily for the remaining 5
      days] or standard 7-day therapy [corrected] [rabeprazole (20 mg), clarithromycin (500 mg) and
      amoxicillin (1 g), all twice daily]. H. pylori status was assessed by histology, rapid urease
      test and 13C-urea breath test at baseline and 6 weeks or more after completion of treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2001</start_date>
  <completion_date>December 2001</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Helicobacter pylori eradication rate</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compliance to therapy</measure>
  </secondary_outcome>
  <enrollment>1000</enrollment>
  <condition>Helicobacter Pylori Infection</condition>
  <condition>Non Ulcer Dyspepsia</condition>
  <condition>Duodenal Ulcer</condition>
  <condition>Gastric Ulcer</condition>
  <condition>Chronic Active Gastritis</condition>
  <condition>Gastritis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sequential therapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presence of active H. pylori infection

          -  Age &gt;18 years

        Exclusion Criteria:

          -  Allergy to drug administered

          -  Liver or kidney failure

          -  Pregnancy

          -  Previous treatment for H. pylori infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Angelo Zullo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nuovo Regina Margherita Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gastroenterology - Nuovo Regina Margherita Hospital</name>
      <address>
        <city>Rome</city>
        <zip>00153</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Zullo A, Vaira D, Vakil N, Hassan C, Gatta L, Ricci C, De Francesco V, Menegatti M, Tampieri A, Perna F, Rinaldi V, Perri F, Papadìa C, Fornari F, Pilati S, Mete LS, Merla A, Potì R, Marinone G, Savioli A, Campo SM, Faleo D, Ierardi E, Miglioli M, Morini S. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther. 2003 Mar 1;17(5):719-26. Erratum in: Aliment Pharmacol Ther. 2003 May 1;17(9):1205.</citation>
    <PMID>12641522</PMID>
  </results_reference>
  <verification_date>March 2002</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2005</study_first_submitted>
  <study_first_submitted_qc>August 18, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2005</study_first_posted>
  <last_update_submitted>October 19, 2005</last_update_submitted>
  <last_update_submitted_qc>October 19, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2005</last_update_posted>
  <keyword>Helicobacter pylori</keyword>
  <keyword>Eradication</keyword>
  <keyword>Sequential therapy</keyword>
  <keyword>Standard therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Dyspepsia</mesh_term>
    <mesh_term>Helicobacter Infections</mesh_term>
    <mesh_term>Gastritis</mesh_term>
    <mesh_term>Stomach Ulcer</mesh_term>
    <mesh_term>Duodenal Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

